341 related articles for article (PubMed ID: 18463008)
1. Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas.
Bettini R; Mantovani W; Boninsegna L; Crippa S; Capelli P; Bassi C; Scarpa A; Pederzoli P; Falconi M
Dig Liver Dis; 2009 Jan; 41(1):49-55. PubMed ID: 18463008
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic resection for metastatic tumors to the pancreas.
Sperti C; Pasquali C; Liessi G; Pinciroli L; Decet G; Pedrazzoli S
J Surg Oncol; 2003 Jul; 83(3):161-6; discussion 166. PubMed ID: 12827684
[TBL] [Abstract][Full Text] [Related]
3. Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
Gleisner AL; Assumpcao L; Cameron JL; Wolfgang CL; Choti MA; Herman JM; Schulick RD; Pawlik TM
Cancer; 2007 Dec; 110(11):2484-92. PubMed ID: 17941009
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma.
Butturini G; Bettini R; Missiaglia E; Mantovani W; Dalai I; Capelli P; Ferdeghini M; Pederzoli P; Scarpa A; Falconi M
Endocr Relat Cancer; 2006 Dec; 13(4):1213-21. PubMed ID: 17158766
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic resection of isolated metastases from nonpancreatic primary cancers.
Reddy S; Edil BH; Cameron JL; Pawlik TM; Herman JM; Gilson MM; Campbell KA; Schulick RD; Ahuja N; Wolfgang CL
Ann Surg Oncol; 2008 Nov; 15(11):3199-206. PubMed ID: 18784960
[TBL] [Abstract][Full Text] [Related]
6. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.
van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ
Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088
[TBL] [Abstract][Full Text] [Related]
7. Extended surgery for advanced pancreatic endocrine tumours.
Kleine M; Schrem H; Vondran FW; Krech T; Klempnauer J; Bektas H
Br J Surg; 2012 Jan; 99(1):88-94. PubMed ID: 22135173
[TBL] [Abstract][Full Text] [Related]
8. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer.
Sierzega M; Popiela T; Kulig J; Nowak K
Pancreas; 2006 Oct; 33(3):240-5. PubMed ID: 17003644
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients.
Kuhlmann KF; de Castro SM; Wesseling JG; ten Kate FJ; Offerhaus GJ; Busch OR; van Gulik TM; Obertop H; Gouma DJ
Eur J Cancer; 2004 Mar; 40(4):549-58. PubMed ID: 14962722
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous hepatic resection with pancreato-duodenectomy for metastatic pancreatic head carcinoma: does it improve survival?
Takada T; Yasuda H; Amano H; Yoshida M; Uchida T
Hepatogastroenterology; 1997; 44(14):567-73. PubMed ID: 9164539
[TBL] [Abstract][Full Text] [Related]
11. Resectional surgical procedures for carcinoma of the head of the pancreas.
Lygidakis NJ; van der Hyde MN; Houthoff HJ; Schipper ME; Huibregtse K; Tytgat GN; Lubber MJ; Reeders JW; Bosey MM; Oosting J
Surg Gynecol Obstet; 1989 Feb; 168(2):157-65. PubMed ID: 2911793
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
Shrikhande SV; Kleeff J; Reiser C; Weitz J; Hinz U; Esposito I; Schmidt J; Friess H; Büchler MW
Ann Surg Oncol; 2007 Jan; 14(1):118-27. PubMed ID: 17066229
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic resection for locally advanced primary and metastatic nonpancreatic neoplasms.
Pingpank JF; Hoffman JP; Sigurdson ER; Ross E; Sasson AR; Eisenberg BL
Am Surg; 2002 Apr; 68(4):337-40; discussion 340-1. PubMed ID: 11952243
[TBL] [Abstract][Full Text] [Related]
14. Pancreaticoduodenectomy for pancreatic metastases from breast carcinoma.
Crippa S; Bonardi C; Bovo G; Mussi C; Angelini C; Uggeri F
JOP; 2004 Sep; 5(5):377-83. PubMed ID: 15365207
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic head carcinoma: clinical analysis of 189 cases.
Hua YP; Liang LJ; Peng BG; Li SQ; Huang JF
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):79-84. PubMed ID: 19208521
[TBL] [Abstract][Full Text] [Related]
16. Clinical results on intra-arterial adjuvant chemotherapy for prevention of liver metastasis following curative resection of pancreatic cancer.
Hayashibe A; Kameyama M; Shinbo M; Makimoto S
Ann Surg Oncol; 2007 Jan; 14(1):190-4. PubMed ID: 17066232
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.
Golcher H; Brunner T; Grabenbauer G; Merkel S; Papadopoulos T; Hohenberger W; Meyer T
Eur J Surg Oncol; 2008 Jul; 34(7):756-64. PubMed ID: 18191528
[TBL] [Abstract][Full Text] [Related]
18. Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care.
Smoot RL; Zhang L; Sebo TJ; Que FG
J Am Coll Surg; 2008 Sep; 207(3):368-70. PubMed ID: 18722942
[TBL] [Abstract][Full Text] [Related]
19. Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?
Teh SH; Deveney C; Sheppard BC
Am J Surg; 2007 May; 193(5):610-3; discussion 613. PubMed ID: 17434366
[TBL] [Abstract][Full Text] [Related]
20. Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation.
Bertani E; Fazio N; Radice D; Zardini C; Spinoglio G; Chiappa A; Ribero D; Biffi R; Partelli S; Falconi M
Eur J Surg Oncol; 2017 Feb; 43(2):372-379. PubMed ID: 27742480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
